Clinical Trial of New Targeted Agent a Boon for Patient With AML 

When Youling Sun was diagnosed in Shanghai, China, with acute myeloid leukemia (AML) in 2018, he called his son, Conghao, in Boston, for advice. His son’s message was unequivocal: Come to Boston for your treatment.  Today, Sun, a retired office worker from Shanghai, has multiple reasons to be thankful he took that advice — both … Read more

Multiple Myeloma Patient Shines Bright as CAR T-Cell Therapy Outpatient 

As a systems operator who works to help maintain the electrical grid for New York state, Brian Houlihan, 46, is used to getting power to the people. But when the multiple myeloma he has lived with since 2011 stopped responding to chemotherapy, it was Houlihan who needed a recharge.  He got it, through an innovative … Read more

PSA and PSMA: What is the Difference? 

Prostate cancer is the second most common cause of cancer in men worldwide as of 2020, and cases of advanced prostate cancer continue to rise.  Early detection of prostate cancer is essential for effective treatment. Dana-Farber physicians recommend having a conversation with a medical professional about screening around the age of 40, or perhaps even … Read more

How Dana-Farber Investigators Seize Opportunities to Advance Medicine

Investigators who run investigator-initiated trials (IITs) have two essential qualities. One is curiosity, which keeps them alert, aware of discoveries, and able to make connections that lead to new treatment ideas.   The second is determination.   “The burden of responsibility for what is typically a many-year-long study falls on that one investigator,” says Ursula Matulonis, MD, … Read more

Lumpectomy vs. Mastectomy: Five Things to Consider 

A frequent component of treatment for breast cancer is surgery to remove the cancer.   While mastectomy was more common in decades past, experts at Dana-Farber want you to know that science and treatment have advanced. Improved screening, early diagnosis, and advances in medicine are enabling many more patients to have the option of breast-conserving surgery, … Read more